Gensol Engineering was locked in a 5% lower circuit at Rs 261.70, extending losses for the thirteenth consecutive trading session.

The Phase 1 trial of the second-generation triterpenoid antifungal SCY-247, initiated in December of 2024, continues and results are expected in Q3 of 2025.Four presentations for SCY-247 were accepted ...

JSW Energy said that it has signed a power purchase agreement (PPA) with West Bengal State Electricity Distribution Company (WBSEDCL) for a Greenfield 1,600 MW (2 x 800 MW) supercritical thermal power ...

PB Fintech shares crashed over 5% in early trade on the BSE to hit an intraday low of INR 1,332, extending their losses for ...

The Mumbai Metropolitan Region (MMR) residential market, including apartments, plots, and villas, recorded 68,082 registered ...

ICRA reports decline in collection efficiency for unsecured asset classes like microfinance, personal loans, and SME loans in ...

The collection efficiency trend for unsecured asset classes, such as microfinance loans, personal loans and unsecured SME ...

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

The total number of deals up for renewal has been declining year-over-year. In 2023, 1,374 deals were up for renewal, which ...

According to a Goldman Sachs report released this week, U.S. copper imports could skyrocket by 50% to 100% in the coming months ahead of the Trump ...

PHILADELPHIA, PA, AND NEW YORK, NY — Cohen & Company Inc. (NYSE American: COHN) has released its financial results for the ...

Ubisoft is accused of talking to Microsoft, Electronic Arts, and other publishers about acquiring IPs from Ubisoft without ...